1. Home
  2. RGEN vs MKSI Comparison

RGEN vs MKSI Comparison

Compare RGEN & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MKSI
  • Stock Information
  • Founded
  • RGEN 1981
  • MKSI 1961
  • Country
  • RGEN United States
  • MKSI United States
  • Employees
  • RGEN N/A
  • MKSI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MKSI Industrial Machinery/Components
  • Sector
  • RGEN Health Care
  • MKSI Industrials
  • Exchange
  • RGEN Nasdaq
  • MKSI Nasdaq
  • Market Cap
  • RGEN 8.0B
  • MKSI 5.0B
  • IPO Year
  • RGEN N/A
  • MKSI 1999
  • Fundamental
  • Price
  • RGEN $127.47
  • MKSI $104.56
  • Analyst Decision
  • RGEN Buy
  • MKSI Buy
  • Analyst Count
  • RGEN 12
  • MKSI 11
  • Target Price
  • RGEN $170.40
  • MKSI $131.73
  • AVG Volume (30 Days)
  • RGEN 685.0K
  • MKSI 943.2K
  • Earning Date
  • RGEN 07-29-2025
  • MKSI 08-06-2025
  • Dividend Yield
  • RGEN N/A
  • MKSI 0.84%
  • EPS Growth
  • RGEN N/A
  • MKSI N/A
  • EPS
  • RGEN N/A
  • MKSI 3.36
  • Revenue
  • RGEN $650,429,000.00
  • MKSI $3,654,000,000.00
  • Revenue This Year
  • RGEN $13.93
  • MKSI $7.00
  • Revenue Next Year
  • RGEN $14.35
  • MKSI $6.70
  • P/E Ratio
  • RGEN N/A
  • MKSI $31.14
  • Revenue Growth
  • RGEN 4.88
  • MKSI N/A
  • 52 Week Low
  • RGEN $102.97
  • MKSI $54.84
  • 52 Week High
  • RGEN $182.52
  • MKSI $147.40
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.11
  • MKSI 71.72
  • Support Level
  • RGEN $121.44
  • MKSI $97.16
  • Resistance Level
  • RGEN $131.43
  • MKSI $100.80
  • Average True Range (ATR)
  • RGEN 4.47
  • MKSI 3.03
  • MACD
  • RGEN 0.61
  • MKSI 0.73
  • Stochastic Oscillator
  • RGEN 74.57
  • MKSI 94.46

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

Share on Social Networks: